Deutsche Bank Ag\ Imago Bio Sciences, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$15.03 - $35.96 $15,255 - $36,499	1,015 Added 9.16%	12,094 $434,000
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $24,904 - $34,320	-1,760 Reduced 13.71%	11,079 $167,000
Q2 2022 Aug 11, 2022	BUY	$11.81 - $20.92 $15,093 - $26,735	1,278 Added 11.05%	12,839 $172,000
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $95,931 - $141,325	5,653 Added 95.68%	11,561 $223,000
Q4 2021 Feb 11, 2022	BUY	$16.22 - $29.69 $4,898 - $8,966	302 Added 5.39%	5,908 $140,000
Q3 2021 Nov 04, 2021	BUY	$16.0 - $28.84 $89,696 - $161,677	5,606 New	5,606 $112,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.